We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
(+3.2%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$67.7M |
| 2 |
Corteva
CTVA
|
+$33.4M |
| 3 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$19.3M |
| 4 |
Spotify
SPOT
|
+$15.3M |
| 5 |
Amcor
AMCR
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$62.6M |
| 2 |
Apple
AAPL
|
+$51.5M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$29.7M |
| 4 |
NXP Semiconductors
NXPI
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 15.55% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCCY
2801
DELISTED
1st Constitution Bancorp
FCCY
| $188K | ﹤0.01% |
+10,159
| New | +$189K |
|
2802
IDT Corp
IDT
$1.65B
| $187K | ﹤0.01% |
+19,771
| New | +$146K |
|
2803
The Joint Corp
JYNT
$117M
| $187K | ﹤0.01% |
+10,280
| New | +$175K |
|
2804
Verrica Pharmaceuticals
VRCA
$90.2M
| $186K | ﹤0.01% |
1,602
+577
| +56% | +$54.1K |
|
|
RNET
2805
DELISTED
RigNet, Inc.
RNET
| $186K | ﹤0.01% |
18,430
-1,157
| -6% | -$10.7K |
|
2806
Stagwell
STGW
$2.13B
| $184K | ﹤0.01% |
72,914
+1,104
| +2% | +$2.84K |
|
|
PRGX
2807
DELISTED
PRGX Global, Inc.
PRGX
| $184K | ﹤0.01% |
27,384
+376
| +1% | +$2.7K |
|
2808
CEL-SCI Corp
CVM
$21.8M
| $183K | ﹤0.01% |
+729
| New | +$132K |
|
|
DOVA
2809
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $182K | ﹤0.01% |
12,927
-2,227
| -15% | -$21.2K |
|
2810
Ardelyx
ARDX
$1.23B
| $181K | ﹤0.01% |
67,217
+6,641
| +11% | +$20K |
|
2811
DHI Group
DHX
$175M
| $181K | ﹤0.01% |
+50,733
| New | +$176K |
|
2812
Forte Biosciences
FBRX
$1.57B
| $181K | ﹤0.01% |
72
+4
| +6% | +$11.9K |
|
2813
Lineage Cell Therapeutics
LCTX
$277M
| $181K | ﹤0.01% |
164,208
+21,412
| +15% | +$24.7K |
|
|
NESR
2814
National Energy Services Reunited Corp
NESR
$2.8B
| $181K | ﹤0.01% |
+20,833
| New | +$199K |
|
|
GTYH
2815
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $181K | ﹤0.01% |
+26,456
| New | +$231K |
|
2816
Aldeyra Therapeutics
ALDX
$92.3M
| $180K | ﹤0.01% |
29,935
+2,752
| +10% | +$20.7K |
|
2817
Escalade
ESCA
$294M
| $180K | ﹤0.01% |
15,651
+184
| +1% | +$2.13K |
|
|
PYX
2818
DELISTED
Pyxus International, Inc.
PYX
| $180K | ﹤0.01% |
11,816
+172
| +1% | +$3.24K |
|
2819
American Superconductor
AMSC
$1.5B
| $179K | ﹤0.01% |
+19,260
| New | +$205K |
|
2820
Ascent Industries
ACNT
$140M
| $178K | ﹤0.01% |
11,413
+294
| +3% | +$5.07K |
|
2821
Novavax
NVAX
$1.22B
| $178K | ﹤0.01% |
30,310
+4,107
| +16% | +$32.3K |
|
|
PRTK
2822
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $178K | ﹤0.01% |
44,718
+4,380
| +11% | +$20.8K |
|
|
AMRS
2823
DELISTED
Amyris Inc.
AMRS
| $178K | ﹤0.01% |
49,879
+7,614
| +18% | +$30K |
|
2824
Adicet Bio
ACET
$86.4M
| $177K | ﹤0.01% |
155
+65
| +72% | +$58.9K |
|
|
ITI
2825
DELISTED
Iteris, Inc.
ITI
| $177K | ﹤0.01% |
34,296
+2,240
| +7% | +$10.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
- RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
- RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
- RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
- RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
- RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.